STANELCO Plc>>THE LATEST INFORMATION.

From the fund raising RNS 9/10/2006

Specifically, funds raised will be used to ensure successful completion by
either Biotec, or under the joint venture agreement, Stanelco of at least the
first two manufacturing facilities in the US, which will cost around 2.8 mln stg
each, for the production of starch-based resins, including Starpol materials,
developed by Biotec.
In addition, Stanelco said it will use funds to meet the final stage payment
of 1.6 mln stg due in June 2007 to EKI for the Biotec acquisition.
newsdesk@afxnews.com
slm


note Biotech , or under joint venture agreement ( sphere ??? )